
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts

Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561

The 2024-2025 FasterCures LeadersLink Cohort

TRAIN Newsletter — April 2024

FasterCures Quarterly Update—April 2024

Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
